279 related articles for article (PubMed ID: 35575930)
1. HDL and Therapy.
Li K; Xie X; Guo Y
Adv Exp Med Biol; 2022; 1377():171-187. PubMed ID: 35575930
[TBL] [Abstract][Full Text] [Related]
2. Recombinant high-density lipoproteins and their use in cardiovascular diseases.
Cao YN; Xu L; Han YC; Wang YN; Liu G; Qi R
Drug Discov Today; 2017 Jan; 22(1):180-185. PubMed ID: 27591840
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.
Osei-Hwedieh DO; Amar M; Sviridov D; Remaley AT
Pharmacol Ther; 2011 Apr; 130(1):83-91. PubMed ID: 21172387
[TBL] [Abstract][Full Text] [Related]
4. HDL therapy for the treatment of cardiovascular diseases.
Parolini C; Marchesi M; Chiesa G
Curr Vasc Pharmacol; 2009 Oct; 7(4):550-6. PubMed ID: 19485919
[TBL] [Abstract][Full Text] [Related]
5. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.
Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA
Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776
[TBL] [Abstract][Full Text] [Related]
6. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases.
Wolska A; Reimund M; Sviridov DO; Amar MJ; Remaley AT
Cells; 2021 Mar; 10(3):. PubMed ID: 33800446
[TBL] [Abstract][Full Text] [Related]
8. Peptides as Therapeutic Agents for Atherosclerosis.
White CR; Palgunachari M; Wolkowicz P; Anantharamaiah GM
Methods Mol Biol; 2022; 2419():89-110. PubMed ID: 35237960
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of high-density lipoproteins: biochemical basis and clinical findings.
Chiesa G; Parolini C; Sirtori CR
Curr Opin Cardiol; 2008 Jul; 23(4):379-85. PubMed ID: 18520723
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of recombinant high density lipoprotein with apolipoprotein A-I and apolipoprotein A-V.
Zhang X; Chen B
Biol Chem; 2011 May; 392(5):423-9. PubMed ID: 21476871
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
[TBL] [Abstract][Full Text] [Related]
12. ApoA-I mimetics.
Stoekenbroek RM; Stroes ES; Hovingh GK
Handb Exp Pharmacol; 2015; 224():631-48. PubMed ID: 25523005
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I mimetics and high-density lipoprotein function.
Gordon SM; Davidson WS
Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):109-14. PubMed ID: 22278086
[TBL] [Abstract][Full Text] [Related]
14. Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.
Murphy AJ; Funt S; Gorman D; Tall AR; Wang N
Circ Res; 2013 Jun; 113(1):e1-e9. PubMed ID: 23613182
[TBL] [Abstract][Full Text] [Related]
15. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I mimetic peptides.
Hovingh GK; Bochem AE; Kastelein JJ
Curr Opin Lipidol; 2010 Dec; 21(6):481-6. PubMed ID: 21042216
[TBL] [Abstract][Full Text] [Related]
17. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
19. The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
Valanti EK; Chroni A; Sanoudou D
Curr Opin Lipidol; 2019 Aug; 30(4):326-341. PubMed ID: 31157629
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-II modulates the binding and selective lipid uptake of reconstituted high density lipoprotein by scavenger receptor BI.
de Beer MC; Durbin DM; Cai L; Mirocha N; Jonas A; Webb NR; de Beer FC; van Der Westhuyzen DR
J Biol Chem; 2001 May; 276(19):15832-9. PubMed ID: 11279034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
